We are pleased to announce that Suzhou Connect Biopharma has established a wholly owned subsidiary, Australia Pty Ltd, in Melbourne, Australia on the 18th of July 2014. The establishment of our Australian subsidiary is an important strategic step in our operation. It will allow us to better execute the development of our clinical pipeline by working with the top quality clinical study centers and related CROs in the Australia.